{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:21:56Z","timestamp":1785878516500,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY21H160052"],"award-info":[{"award-number":["LY21H160052"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Medicine and Health Research Foundation","award":["2018KY246, 2019KY020"],"award-info":[{"award-number":["2018KY246, 2019KY020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dermatofibrosarcoma protuberans (DFSP) is a superficial fibroblastic tumor characterized by high rate of local recurrence and low metastatic potential. Fibrosarcomatous transformation can rarely arise in DFSP either de novo or as recurrent, which represents a form of tumor progression and carries an increased risk of metastasis over classic DFSP. Cytogenetically, DFSP is characterized by a recurrent unbalanced chromosome translocation t (17;22)(q22;q13), leading to the formation of <jats:italic>COL1A1-PDGFB<\/jats:italic> fusion transcript that is present in more than 90% of cases. Alternative fusions involving the <jats:italic>PDGFD<\/jats:italic> with partners of <jats:italic>COL6A3<\/jats:italic> or <jats:italic>EMILIN2<\/jats:italic> have recently been documented in less than 2% of cases. Herein, we report a DFSP with fibrosarcomtous morphology harboring a novel <jats:italic>TNC-PDGFD<\/jats:italic> fusion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 54-year-old female presented with a slowly growing mass in the right thigh. Excision demonstrated a 2-cm ovoid, well-circumscribed, gray-white, mass. Microscopic examination revealed a partially encapsulated subcutaneous nodule without dermal connection. The neoplasm was composed of cellular and fairly uniform spindle cells with brisk mitoses, arranged in elongated fascicles and herringbone patterns, with focal collagenized stroma. The neoplastic cells were positive for CD34 and smooth muscle actin. Fluorescence in-situ hybridization analyses showed negative for <jats:italic>COL1A1-PDGFB<\/jats:italic> fusion as well as <jats:italic>NTRK1\/2\/3<\/jats:italic> rearrangements. A subsequent RNA sequencing detected an in-frame fusion between exon 15 of <jats:italic>TNC<\/jats:italic> and exon 6 of <jats:italic>PDGFD<\/jats:italic>. This fusion was further confirmed by nested reverse transcription polymerase chain reaction amplification followed by Sanger sequencing. A diagnosis of fibrosarcomatous DFSP was rendered and the patient was in good status at a follow-up of 12\u2009months after the operation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We report a fibrosarcomatous DFSP with novel <jats:italic>TNC-PDGFD<\/jats:italic> fusion, which adds to the pathologic and genetic spectrum of <jats:italic>PDGFD-<\/jats:italic>rearranged DFSP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-021-01123-1","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T07:03:06Z","timestamp":1626159786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Novel TNC-PDGFD fusion in fibrosarcomatous dermatofibrosarcoma protuberans: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Yuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-zhou","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-he","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-lei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-7303","authenticated-orcid":false,"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"key":"1123_CR1","volume-title":"WHO Classification of Tumours of Soft Tissue and Bone","author":"WHO Classification of Tumours Editorial Board","year":"2020","unstructured":"WHO Classification of Tumours Editorial Board. WHO Classification of Tumours of Soft Tissue and Bone. 5th ed. Lyon, France: IARC Press; 2020.","edition":"5"},{"key":"1123_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.anndiagpath.2016.09.013","volume":"25","author":"K Thway","year":"2016","unstructured":"Thway K, Noujaim J, Jones RL, Fisher C. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies. Ann Diagn Pathol. 2016;25:64\u201371. https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.09.013.","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"1123_CR3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/00000478-199805000-00009","volume":"22","author":"T Mentzel","year":"1998","unstructured":"Mentzel T, Beham A, Katenkamp D, Dei Tos AP, Fletcher CD. Fibrosarcomatous (\u201chigh-grade\u201d) dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol. 1998;22(5):576\u201387. https:\/\/doi.org\/10.1097\/00000478-199805000-00009.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1123_CR4","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/00000478-200604000-00002","volume":"30","author":"JJ Abbott","year":"2006","unstructured":"Abbott JJ, Oliveira AM, Nascimento AG. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans. Am J Surg Pathol. 2006;30(4):436\u201343. https:\/\/doi.org\/10.1097\/00000478-200604000-00002.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1123_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ng0197-95","volume":"15","author":"MP Simon","year":"1997","unstructured":"Simon MP, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre JM, et al. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet. 1997;15(1):95\u20138. https:\/\/doi.org\/10.1038\/ng0197-95.","journal-title":"Nat Genet"},{"issue":"1","key":"1123_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gcc.10202","volume":"37","author":"N Sirvent","year":"2003","unstructured":"Sirvent N, Maire G, Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosom Cancer. 2003;37(1):1\u201319. https:\/\/doi.org\/10.1002\/gcc.10202.","journal-title":"Genes Chromosom Cancer"},{"issue":"12","key":"1123_CR7","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jamadermatol.2015.2389","volume":"151","author":"I Nakamura","year":"2015","unstructured":"Nakamura I, Kariya Y, Okada E, Yasuda M, Matori S, Ishikawa O, et al. A novel chromosomal translocation associated with COL1A2-PDGFB gene fusion in dermatofibrosarcoma protuberans: PDGF expression as a new diagnostic tool. JAMA Dermatol. 2015;151(12):1330\u20137. https:\/\/doi.org\/10.1001\/jamadermatol.2015.2389.","journal-title":"JAMA Dermatol"},{"issue":"9","key":"1123_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/gcc.22663","volume":"57","author":"BC Dickson","year":"2018","unstructured":"Dickson BC, Hornick JL, Fletcher CDM, Demicco EG, Howarth DJ, Swanson D, et al. Dermatofibrosarcoma protuberans with a novel COL6A3-PDGFD fusion gene and apparent predilection for breast. Genes Chromosom Cancer. 2018;57(9):437\u201345. https:\/\/doi.org\/10.1002\/gcc.22663.","journal-title":"Genes Chromosom Cancer"},{"issue":"11","key":"1123_CR9","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/s41379-018-0089-4","volume":"31","author":"B Dadone-Montaudi\u00e9","year":"2018","unstructured":"Dadone-Montaudi\u00e9 B, Alberti L, Duc A, Delespaul L, Lesluyes T, P\u00e9rot G, et al. Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions. Mod Pathol. 2018;31(11):1683\u201393. https:\/\/doi.org\/10.1038\/s41379-018-0089-4.","journal-title":"Mod Pathol"},{"issue":"4","key":"1123_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/PAS.0000000000001408","volume":"44","author":"QY Xia","year":"2020","unstructured":"Xia QY, Wang XT, Fang R, et al. Clinicopathologic and molecular analysis of the TFEB fusion variant reveals new members of TFEB translocation renal cell carcinomas (RCCs): expanding the genomic Spectrum. Am J Surg Pathol. 2020;44(4):477\u201389. https:\/\/doi.org\/10.1097\/PAS.0000000000001408.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"1123_CR11","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/sj.onc.1202051","volume":"17","author":"A Greco","year":"1998","unstructured":"Greco A, Fusetti L, Villa R, Sozzi G, Minoletti F, Mauri P, et al. Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans. Oncogene. 1998;17(10):1313\u20139. https:\/\/doi.org\/10.1038\/sj.onc.1202051.","journal-title":"Oncogene."},{"issue":"17","key":"1123_CR12","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1016\/j.ejca.2015.06.108","volume":"51","author":"P Saiag","year":"2015","unstructured":"Saiag P, Grob JJ, Lebbe C, Malvehy J, del Marmol V, Pehamberger H, et al. Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline. Eur J Cancer. 2015;51(17):2604\u20138. https:\/\/doi.org\/10.1016\/j.ejca.2015.06.108.","journal-title":"Eur J Cancer"},{"issue":"2","key":"1123_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/modpathol.2014.97","volume":"28","author":"M Karanian","year":"2015","unstructured":"Karanian M, P\u00e9rot G, Coindre JM, Chibon F, Pedeutour F, Neuville A. Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans. Mod Pathol. 2015;28(2):230\u20137. https:\/\/doi.org\/10.1038\/modpathol.2014.97.","journal-title":"Mod Pathol"},{"issue":"1","key":"1123_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/138945009787122914","volume":"10","author":"Z Wang","year":"2009","unstructured":"Wang Z, Kong D, Li Y, Sarkar FH. PDGF-D signaling: a novel target in cancer therapy. Curr Drug Targets. 2009;10(1):38\u201341. https:\/\/doi.org\/10.2174\/138945009787122914.","journal-title":"Curr Drug Targets"},{"issue":"1","key":"1123_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bbcan.2010.04.003","volume":"1806","author":"Z Wang","year":"2010","unstructured":"Wang Z, Ahmad A, Li Y, Kong D, Azmi AS, Banerjee S, et al. Emerging roles of PDGF-D signaling pathway in tumor development and progression. Biochim Biophys Acta. 2010;1806(1):122\u201330. https:\/\/doi.org\/10.1016\/j.bbcan.2010.04.003.","journal-title":"Biochim Biophys Acta"},{"issue":"23","key":"1123_CR16","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1242\/jcs.190546","volume":"129","author":"KS Midwood","year":"2016","unstructured":"Midwood KS, Chiquet M, Tucker RP, Orend G. Tenascin-C at a glance. J Cell Sci. 2016;129(23):4321\u20137. https:\/\/doi.org\/10.1242\/jcs.190546.","journal-title":"J Cell Sci"},{"issue":"1\u20132","key":"1123_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/19336918.2015.1008333","volume":"9","author":"F Chiovaro","year":"2015","unstructured":"Chiovaro F, Chiquet-Ehrismann R, Chiquet M. Transcriptional regulation of tenascin genes. Cell Adhes Migr. 2015;9(1\u20132):34\u201347. https:\/\/doi.org\/10.1080\/19336918.2015.1008333.","journal-title":"Cell Adhes Migr"},{"issue":"1\u20132","key":"1123_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/19336918.2015.1008332","volume":"9","author":"T Yoshida","year":"2015","unstructured":"Yoshida T, Akatsuka T, Imanaka-Yoshida K. Tenascin-C and integrins in cancer. Cell Adhes Migr. 2015;9(1\u20132):96\u2013104. https:\/\/doi.org\/10.1080\/19336918.2015.1008332.","journal-title":"Cell Adhes Migr"},{"issue":"16","key":"1123_CR19","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1158\/1078-0432.CCR-19-0160","volume":"25","author":"S Jonna","year":"2019","unstructured":"Jonna S, Feldman RA, Swensen J, Gatalica Z, Korn WM, Borghaei H, et al. Detection of NRG1 gene fusions in solid tumors. Clin Cancer Res. 2019;25(16):4966\u201372. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0160.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1123_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/gcc.22942","volume":"60","author":"N Pt\u00e1kov\u00e1","year":"2021","unstructured":"Pt\u00e1kov\u00e1 N, Mart\u00ednek P, Holubec L, Janovsk\u00fd V, Van\u010durov\u00e1 J, Grossmann P, et al. Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database. Genes Chromosom Cancer. 2021;60(7):474\u201381. https:\/\/doi.org\/10.1002\/gcc.22942.","journal-title":"Genes Chromosom Cancer"},{"issue":"6","key":"1123_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/gcc.22836","volume":"59","author":"D \u0160ekoranja","year":"2020","unstructured":"\u0160ekoranja D, Zupan A, Mav\u010di\u010d B, Martin\u010di\u010d D, Salapura V, Snoj \u017d, et al. Novel ASAP1-USP6, FAT1-USP6, SAR1A-USP6, and TNC-USP6 fusions in primary aneurysmal bone cyst. Genes Chromosom Cancer. 2020;59(6):357\u201365. https:\/\/doi.org\/10.1002\/gcc.22836.","journal-title":"Genes Chromosom Cancer"},{"issue":"4","key":"1123_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11864-019-0628-3","volume":"20","author":"T Iwasaki","year":"2019","unstructured":"Iwasaki T, Yamamoto H, Oda Y. Current update on the molecular biology of cutaneous sarcoma: dermatofibrosarcoma protuberans. Curr Treat Options in Oncol. 2019;20(4):29. https:\/\/doi.org\/10.1007\/s11864-019-0628-3.","journal-title":"Curr Treat Options in Oncol"},{"issue":"5","key":"1123_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3892\/mco.2017.1197","volume":"6","author":"K Tsuchihashi","year":"2017","unstructured":"Tsuchihashi K, Kusaba H, Yamada Y, Okumura Y, Shimokawa H, Komoda M, et al. Programmed death-ligand 1 expression is associated with fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Mol Clin Oncol. 2017;6(5):665\u20138. https:\/\/doi.org\/10.3892\/mco.2017.1197.","journal-title":"Mol Clin Oncol"},{"issue":"7","key":"1123_CR24","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/cup.13469","volume":"46","author":"N Maloney","year":"2019","unstructured":"Maloney N, Bridge JA, de Abreu F, Korkolopoulou P, Sakellariou S, Linos K. A novel MAP 3K7CL-ERG fusion in a molecularly confirmed case of dermatofibrosarcoma protuberans with fibrosarcomatous transformation. J Cutan Pathol. 2019;46(7):532\u20137. https:\/\/doi.org\/10.1111\/cup.13469.","journal-title":"J Cutan Pathol"},{"issue":"6","key":"1123_CR25","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1158\/1535-7163.MCT-14-0793","volume":"14","author":"G Eilers","year":"2015","unstructured":"Eilers G, Czaplinski JT, Mayeda M, Bahri N, Tao D, Zhu M, et al. CDKN2A\/p16 loss implicates CDK4 as a therapeutic target in Imatinib-resistant dermatofibrosarcoma protuberans. Mol Cancer Ther. 2015;14(6):1346\u201353. https:\/\/doi.org\/10.1158\/1535-7163.MCT-14-0793.","journal-title":"Mol Cancer Ther"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01123-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-021-01123-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01123-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T07:07:03Z","timestamp":1626160023000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-021-01123-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1123"],"URL":"https:\/\/doi.org\/10.1186\/s13000-021-01123-1","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,13]]},"assertion":[{"value":"5 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Samples were used in accordance with ethical guidelines for the use of retrospective tissue samples provided by the local ethics committee of the Zhejiang Provincial People\u2019s Hospital, People\u2019s Hospital of Hangzhou Medical College.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}